Chronic Hepatitis

Top Story

About one in five Americans with RA gets tested for hepatitis B

March 24, 2017

Among patients with rheumatoid arthritis, the overall hepatitis B testing rate was 20.3% in the United States and 24.5% in Taiwan, according to recently published data.

“[We] found the [hepatitis B virus] HBV testing rates were low in the [United States] U.S. as well as Taiwan, although it gradually increased in both countries over the last decade,” Tzu-Chieh Lin, PhD, in the Division of Rheumatology, Immunology and Allergy at Brigham and Women’s Hospital, and colleagues wrote. “The uncertainty of universal or risk-based testing strategies may be one of the reasons for non-specific ACR recommendations, leading to low testing rates.”

In the Journals

Multiple oral direct-acting antiviral regimens effectively treat HCV

March 20, 2017
FDA-approved oral direct-acting agent therapy produced high rates of safety, tolerability and efficacy for treating hepatitis C virus infection, especially for patient…
In the Journals Plus

Ribavirin with regimen effective in HIV/HCV coinfected patients on Prezista

March 20, 2017
In a small cohort study, ribavirin combined with a regimen for HIV-1 and hepatitis C genotype 1 coinfection was safe and effective in patients also receiving Prezista…
In the Journals

Online resource for HPS focuses on patient-friendly information

March 17, 2017
Researchers have developed a new online education resource for patients with hepatopulmonary syndrome and their caregivers that they designed using evidence-based…
CME

HCV Updates and Case Challenges for the Rapidly Changing Landscape

This activity is supported by an educational grant from Merck & Co., Inc.

In the past few years, significant progress has been made in the treatment of chronic hepatitis C virus (HCV). Highly…
More »
GI Bookshelf

Chapter 6: Nutrients To Nourish The Organisms: Prebiotics And Fiber

From Probiotics: A Clinical Guide
More »
Featured
Video
Meeting News

VIDEO: Pangenotypic regimen leads to high SVR in all HCV genotypes

December 2, 2016
More »
In the Journals

About one in five Americans with RA gets tested for hepatitis B

March 24, 2017
Among patients with rheumatoid arthritis, the overall hepatitis B testing rate was 20.3% in the United States and 24.5% in Taiwan, according to…

In the Journals

Multiple oral direct-acting antiviral regimens effectively treat HCV

March 20, 2017
FDA-approved oral direct-acting agent therapy produced high rates of safety, tolerability and efficacy for treating hepatitis C virus infection…

In the Journals Plus

Ribavirin with regimen effective in HIV/HCV coinfected patients on Prezista

March 20, 2017
In a small cohort study, ribavirin combined with a regimen for HIV-1 and hepatitis C genotype 1 coinfection was safe and effective in patients also…

In the Journals

Online resource for HPS focuses on patient-friendly information

March 17, 2017
Researchers have developed a new online education resource for patients with hepatopulmonary syndrome and their caregivers that they designed using…

In the Journals

Outcomes after HCV-related HCC resection unaffected by diabetes

March 14, 2017
Diabetes did not affect the surgical outcomes of patients with hepatitis C-related hepatocellular carcinoma following liver resection, according to…

In the Journals

Coffee consumption associated with reduced risk for chronic liver disease

March 14, 2017
Recent study data revealed an association between coffee consumption and a reduced risk for developing chronic liver disease, particularly in…

In the Journals

HCV testing remains low among baby boomers, awareness needed

March 8, 2017
Despite a recommendation from the United States Preventive Services Task Force in 2013 for one-time hepatitis C testing among baby boomers, only…

In the Journals

Introduction of DAAs increased treatment, SVR rates in veterans

March 8, 2017
The introduction of direct-acting antiviral therapy in 2013 led to a significant increase in the number of veterans treated for hepatitis C and in…

Technivie expands to HCV genotype 4 with compensated cirrhosis

March 3, 2017
The FDA approved expansion of the indication for Technivie to include patients with chronic hepatitis C genotype 4 with compensated cirrhosis…

In the Journals

Directed testing more cost effective in common liver disease cases

March 2, 2017
Directed testing for patients exhibiting signs of common liver diseases saves time, money and results in fewer false positives compared with…

More Headlines »
Advertisement
Advertisement